Scale -


  • Revenue is 3961 Rs Cr; Annual Growth is 46 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 18 %
  • Ebitda is 516 Rs Cr; Annual Growth is 31 %; Continuous Growth over 3 years; in Top Quartile
  • PBT is 162 Rs Cr; in Top Quartile; Annual Decline is -36 %
  • PAT is 197 Rs Cr; in Top Quartile; Annual Decline is -43 %; 5 Year CAGR is -11 %
  • Quarterly Revenue is 1430 Rs Cr; in Top Quartile

Profitability -


  • Quarterly Ebitda Margin is 17 %; in Top Quartile
  • PAT Margin is 4.97 %; Annual Decline is -61 %; 5 Year CAGR is -25 %

Return -


  • Asset Turnover is 47 %; Continuous Growth over 3 years; 5 Year CAGR is 85 %; in Bottom Quartile
  • ROCE is 3.85 %; Annual Decline is -40 %
  • ROA is 1.91 %; Annual Decline is -64 %; 5 Year CAGR is -23 %
  • ROE is 3.38 %; Annual Decline is -45 %

Efficiency -


  • Inventory Turnover Ratio is 6.18; Continuous Growth over 3 years; 5 Year CAGR is 68 %
  • Operating cash flow is 226 Rs Cr; in Top Quartile; Annual Decline is -40 %
  • Quick Ratio is 0.83; in Bottom Quartile

Solvancy -


  • Debt/Equity is 0.55; Annual Growth is 1733 %; in Top Quartile; 5 Year CAGR is 62 %
  • Total Debt is 3186 Rs Cr; Annual Growth is 1622 %; in Top Quartile; 5 Year CAGR is 70 %
  • Long term Debt is 3035 Rs Cr; in Top Quartile; 5 Year CAGR is 164 %
  • Contingent Liabilities is 442 Rs Cr; in Top Quartile

Quality -


  • Exceptional Items/PBT is -18 %; Annual Decline is -1176 %; in Bottom Quartile
  • Operating cashflow/PAT is 115 %; Continuous Growth over 3 years
  • Current Tax/PAT is 16 %; in Bottom Quartile; Annual Growth is 26815 %
  • Operating cashflow/ebitda is 44 %; Annual Decline is -55 %
  • Other Expenses/Total Expenses is 43 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Zydus Wellness Limited Estimates – NSE:ZYDUSWELL
FSSAI questions Nestlé and Zydus Wellness over nutrition claims
Complan boy, Lactogen Pro girl? FSSAI issues notices to Zydus Wellness, Nestlé
Nestle, Zydus Wellness shares plunge to six-month low amid FSSAI action
FSSAI issues notices to Nestlé India, Zydus Wellness over product claims
FSSAI issues notices to Zydus Wellness, Nestle over claims on Complan, infant formula products
FSSAI notices to Nestle India, Zydus Wellness over ‘misleading claims’ in products
Nestle India, Zydus Wellness shares fall over 2% after FSSAI notices over product claims; here's what the issue is about
Nestle, Zydus Wellness Get Notices Over Claims About Infant Nutrition Products, Complan
Nestle, Zydus, Abbott face India scrutiny over claims on children's products